Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merz
Pharma
Acorda files for bankruptcy, inks $185M asset deal to Merz
Merz, in a "stalking horse bid," agreed to pick up Acorda's Parkinson's disease med Inbrija and multiple sclerosis drug Amprya.
Zoey Becker
Apr 9, 2024 8:29am
Merz adds another star to its galaxy of Xeomin partners
Mar 6, 2024 9:30am
Merz Aesthetics signs R&B singer Teyana Taylor as brand partner
Nov 1, 2022 9:30am
Joe Jonas grabs a new gig promoting Merz's Botox rival Xeomin
Aug 16, 2022 10:30am
Beating Botox: Merz and Vensica team up for needleless delivery
Aug 17, 2021 8:15am
Facebook and Instagram grow pharma ads, but search still rules
Jan 4, 2021 10:45am